Cargando…
The (Ir)relevance of Group Size in Health Care Priority Setting: A Reply to Juth
How to handle orphan drugs for rare diseases is a pressing problem in current health-care. Due to the group size of patients affecting the cost of treatment, they risk being disadvantaged in relation to existing cost-effectiveness thresholds. In an article by Niklas Juth it has been argued that it i...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313590/ https://www.ncbi.nlm.nih.gov/pubmed/27734213 http://dx.doi.org/10.1007/s10728-016-0333-3 |